[ET Net News Agency, 23 November 2023] Jefferies lowered its price target for JD Health
(06618) to HKD51 from HKD66 and maintained its "buy" rating.
The research house said it expects +12% YOY for 2023E and an adjusted net margin of
7.0%, and 2024E sales growth of +8% YOY largely on high base from COVID in 1Q23E. (RC)